Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy
A completed clinical trial evaluating PRKAA2 genetic polymorphisms and their association with susceptibility to Type 2 diabetes mellitus and…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease [NA]
This clinical trial evaluated the effect of lisinopril on renal blood flow and its relationship to proteinuria reduction in subjects with Ty…
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Colchicine for Diabetic Nephropathy Trial [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating colchicine for diabetic nephropathy is listed, with the study status currently Unknown.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy [Phase 2]
Phase 2 study evaluating the efficacy and safety of probucol in patients with diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy
A completed clinical trial sponsored by Benha University investigating how common secondary hyperparathyroidism is among patients with diabe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-04-12FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved Solco Healthcare US, LLC's supplemental application for Losartan Potassium, a generic product, enabling its continued marke…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout [Phase 2]
Phase 2 clinical trial evaluating the effect of topiroxostat on urinary albumin excretion in early-stage diabetic nephropathy with hyperuric…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy [Phase 2]
Phase 2 trial investigating N-acetylcysteine and milk thistle for diabetic nephropathy has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients [Phase 2]
A Phase 2 clinical trial assessing the safety and efficacy of VPI-2690B in diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin [Phase 3]
Phase 3 trial MARLINA-T2D evaluated linagliptin for efficacy, safety, and reduction of albuminuria in type 2 diabetes with renal disease; tr…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy [Phase 2]
The update presents Phase 2 efficacy and safety results for MT-3995 in patients with Diabetic Nephropathy. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong [Phase 3]
Open-label Phase 3 tolerability and safety study of KRX-101 in diabetic nephropathy was terminated in Australia, New Zealand, and Hong Kong.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Antiproteinuric Effect of Valsartan and Lisinopril [Phase 4]
This Phase 4 trial assesses the antiproteinuric effects of combining valsartan (ARB) and lisinopril (ACE inhibitor) in patients with hyperte…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 trial assessing valsartan's impact on albuminuria and proteinuria in hypertensive patients with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy [Phase 2]
Phase 2 trial evaluating DW1029M for microalbuminuria in diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes [Phase 2]
Phase 2 trial results show the effect of ruboxistaurin (LY333531) on proteinuria in patients with diabetic nephropathy.
-
CLINICAL_TRIALS research · 2017-01-13Clinical Trial Update: Effect of Oral Supplementation With Curcumin in Patients With Proteinuric Diabetic Kidney Disease [Phase 2]
This is a Phase 2 clinical trial evaluating oral curcumin supplementation in patients with proteinuric diabetic nephropathy, with the study …
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy [Phase 4]
Phase 4 trial evaluating whether adding pentoxifylline to losartan reduces NT-proBNP levels more effectively than increasing the losartan do…
-
FDA approval · 2016-12-06FDA Approved: IRBESARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's supplemental application for IRBESARTAN, enabling the generic ARB formulation to be marketed …
-
FDA approval · 2016-11-16FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for Losartan Potassium, marking an approval of changes to the generic pr…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of Mesenchymal precursor cells for diabetic nephropathy has completed. The spo…
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes [NA]
This clinical trial update notes the completion of a study evaluating carnosine as adjuvant therapy for diabetic nephropathy in children wit…
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease [NA]
A completed clinical trial evaluated febuxostat for effects on adipokines and kidney disease in individuals with diabetic chronic kidney dis…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Rosiglitazone on Microalbuminuria in Type 2 Diabetics [Phase 3]
A Phase 3 trial evaluating rosiglitazone for microalbuminuria in type 2 diabetes has completed. The provided excerpt does not include trial …
-
FDA approval · 2016-09-13FDA Approved: LISINOPRIL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for lisinopril submitted by Aurobindo Pharma Limited under ANDA 077622.